Index.php
Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner Xarelto (rivaroxaban) and suffered critical bleeding events. Pharmaceutical companies, including the makers of Xarelto, have a duty to ensure that their drugs are reasonably safe for use - and failure to accomplish so may possibly be grounds for compensation. Our lawyers are functioning challenging to have those hurt by the drug the compensation they are entitled to.
Even though bleeding is a typical complication linked with anticoagulants, it has been alleged that Xarelto is more dangerous than classic blood thinners simply because no antidote exists to reverse its blood-thinning effects. This means that, in the occasion of an emergency, individuals may possibly be at threat for irreversible bleeding difficulties, including life-threatening internal and gastrointestinal hemorrhaging.
In case you or possibly a loved one particular suffered a significant bleeding occasion soon after taking Xarelto, you may have legal recourse. For a lot more data, speak to us right now to have your xareltolaw.bitbucket.org case reviewed, free of charge.
Compensation Possibilities
xarelto-compensation-photoThe plaintiffs in these lawsuits are in search of compensation from Bayer and Janssen for past and future healthcare bills, lost wages, discomfort and suffering and, in circumstances of death, funeral expenditures. Moreover, they may be seeking punitive damages, which are usually awarded to punish the defendant and deter other organizations from acting similarly.
Why Are Lawsuits Being Filed?
Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is hazardous and defective. The plaintiffs claim that, unlike conventional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Simply because of this, the lawsuits claim, doctors have no effective means of stopping Xarelto users from bleeding within the event of an emergency. Plaintiffs within the lawsuits allege serious and fatal injuries, such as cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.
In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:
The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a protected anticoagulant option.
Doctors and health-related staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the event of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.
Xarelto is linked to severe bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing harmful clotting.
Visit this page for a lot more data on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set
The attorneys in the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.